This Quick Reference is independent exam-prep support for FINRA Series 161 — Supervisory Analyst Qualification Examination (Part I: Regulations). Use it to review the regulatory judgment expected of a supervisory analyst: identifying regulated research, applying conflict rules, checking disclosures, supervising communications, and spotting prohibited conduct.
High-Yield Regulatory Map
| Area | Core idea | Series 161 exam focus |
|---|
| FINRA research rules | Broker-dealer rules for research analysts, research reports, conflicts, disclosures, and supervision | Equity research under Rule 2241; debt research under Rule 2242; analyst independence |
| FINRA communications rules | Standards for communications with the public | Retail vs institutional vs correspondence; fair and balanced content; approval and recordkeeping |
| SEC Regulation AC | Analyst certification rule | Required certifications in research reports and public appearances |
| Securities Act of 1933 | New issue registration, prospectuses, offering communications, liability | Research around offerings; misstatements; underwriting conflicts |
| Securities Exchange Act of 1934 | Secondary trading, antifraud, broker-dealer regulation, reporting, tender/proxy rules | Rule 10b-5, manipulation, insider trading, Reg FD, Reg M |
| Books and records | Required preservation of communications, approvals, certifications, and supervisory records | What must be retained and why |
| Supervision | Written supervisory procedures, principal review, escalation, annual testing | Who approves, who escalates, and what controls prevent violations |
Core Definitions to Know Cold
| Term | Practical meaning | Exam trap |
|---|
| Supervisory analyst | Qualified supervisory person responsible for reviewing/approving research content under firm procedures | Not merely a senior analyst or editor |
| Research analyst | Associated person primarily responsible for preparing research content or whose name appears on the report | Includes named analysts; title alone is not decisive |
| Research report | Written or electronic communication with analysis of securities/issuers and enough information to support an investment decision | A short email, PDF, blog post, or portal note can qualify if it has analysis and a recommendation basis |
| Equity research report | Research report focused on equity securities of individual companies or industries | Broad market commentary may be excluded; issuer-specific analysis may not be |
| Debt research report | Research report focused on debt securities or debt issuers within the scope of debt research rules | Do not automatically apply every equity research rule to institutional debt research |
| Public appearance | Analyst communication in a seminar, webinar, interview, broadcast, podcast, conference, or similar forum | Not a written report, but still subject to disclosures and Regulation AC concepts |
| Subject company | Issuer that is the focus of the research | Conflicts are measured against this issuer |
| Investment banking services | Underwriting, acting as placement agent, merger/acquisition advisory, or similar capital-raising/advisory services | Commercial lending or ordinary trading is not automatically investment banking |
| Research analyst account | Account of the analyst, certain household members, or accounts controlled by the analyst | Personal trading restrictions cannot be avoided by using a related account |
| Institutional investor | Institutional recipient as defined under FINRA rules and firm procedures | Institutional status affects communication review and debt research treatment |
| Retail investor | Investor that is not an institutional investor | Retail distribution usually triggers stricter communications and disclosure expectations |
| Third-party research | Research prepared by someone other than the distributing member firm | Distribution can still create supervisory and disclosure responsibilities |
| Independent third-party research | Third-party research from a source sufficiently independent of the member and subject company | “Third-party” does not always mean “independent” |
Research Report Decision Path
flowchart TD
A[Communication created or distributed] --> B{Written or electronic?}
B -- No --> C{Analyst public appearance?}
C -- Yes --> D[Apply public appearance disclosures and Reg AC controls]
C -- No --> E[Apply general supervision and communications standards]
B -- Yes --> F{Issuer/security-specific analysis?}
F -- No --> G[Likely market/economic commentary; apply communications standards]
F -- Yes --> H{Enough information to support investment decision?}
H -- No --> I[May be sales commentary or institutional communication; supervise content]
H -- Yes --> J{Equity or debt?}
J -- Equity --> K[Apply FINRA equity research rules, disclosures, approvals]
J -- Debt --> L[Apply FINRA debt research rules; check retail vs institutional]
Research Report vs Non-Research Communication
| Communication | Usually research report? | Why |
|---|
| “Buy ABC; 12-month target $60 based on margin expansion” | Yes | Issuer-specific analysis and investment conclusion |
| Full initiation report on XYZ common stock | Yes | Classic equity research report |
| Credit note recommending purchase of ABC bonds | Usually yes | Debt issuer/security analysis |
| Broad market note: “Rates may remain volatile this quarter” | Usually no | Market/economic commentary, not issuer-specific |
| List of earnings dates with no analysis | Usually no | Factual/statistical information only |
| Technical analysis of a broad index | Usually no | Not individual issuer analysis |
| Individual account recommendation by a registered representative | Not necessarily research | May be suitability/best interest communication, not research report |
| Prospectus, proxy statement, or statutory offering document | Usually excluded from research report definition | Governed by offering/proxy rules |
| Internal draft not distributed to customers | Not a customer research report yet | Still subject to confidentiality and supervision |
| Social media post summarizing a rating change | Can be research or retail communication | Format does not avoid the rule |
FINRA Equity Research: Conflict Controls
| Conflict area | What the rules are trying to prevent | Supervisory analyst review point |
|---|
| Investment banking influence | Research used as a reward, inducement, or sales tool for investment banking business | Look for IB pressure, promised favorable coverage, or altered ratings |
| Prepublication review | Non-research personnel shaping research conclusions before publication | Confirm permitted factual/conflict review is controlled and documented |
| Analyst compensation | Analyst pay tied to specific investment banking transactions | Check compensation disclosures and committee documentation |
| Research budget | Budget decisions driven by specific banking deals | Ensure firm procedures separate research resource decisions from transaction rewards |
| Solicitation of banking business | Analyst participation in pitches, road shows, or promises of favorable research | Prohibited conduct; disclosure does not cure it |
| Personal trading | Analyst trading ahead of research or contrary to published views | Check restricted lists, preclearance, blackout periods, and exceptions |
| Selective disclosure | Giving favored clients, sales, trading, or bankers advance access to research conclusions | Verify distribution controls and timing |
| Retaliation | Punishing analysts for unfavorable coverage | Escalate evidence of pressure or retaliation |
| Issuer influence | Subject company editing conclusions, ratings, or targets | Issuer factual review must not become content approval |
Equity Research Disclosures Checklist
For issuer-specific equity research, verify the report includes clear, prominent, current disclosures where applicable.
| Disclosure item | What to check |
|---|
| Rating system | Meanings of ratings such as buy, hold, sell, outperform, market perform |
| Ratings distribution | Firmwide distribution of ratings and investment banking relationships by rating category, if required |
| Price chart | Historical price chart with rating/price target changes when required |
| Valuation method | Basis for price target or recommendation, including key assumptions |
| Risks | Material risks that could prevent the target or recommendation from working |
| Analyst financial interest | Analyst or household ownership/financial interest in the subject company |
| Firm ownership | Firm or affiliate beneficial ownership threshold disclosures, when applicable |
| Market making | Whether the firm makes a market in the subject security, when applicable |
| Investment banking role | Managed/co-managed offering or received investment banking compensation in the relevant lookback period |
| Expected banking compensation | Whether the firm expects or intends to seek investment banking compensation |
| Other compensation | Non-investment-banking compensation or other material business relationships, where required |
| Analyst compensation | Whether analyst compensation is tied to firm revenues or investment banking revenues, as applicable |
| Material conflicts | Any other known material conflict that could affect objectivity |
Debt Research: Retail vs Institutional Treatment
| Issue | Retail debt research | Institutional debt research |
|---|
| Audience | Retail investors or mixed distribution including retail | Eligible institutional investors only |
| Protection level | More similar to equity-style independence and disclosure controls | More flexible if institutional conditions and disclosures are satisfied |
| Sales/trading interaction | More restricted | May allow more interaction, subject to procedures and anti-fraud standards |
| Disclosures | Robust conflict disclosures expected | May use institutional conflict disclosures and notices |
| Opt-in/opt-out concept | Retail protections apply by default for retail recipients | Institutional recipients may have choices under firm procedures |
| Exam trap | Calling a debt note “institutional” does not make it exempt if sent to retail | Institutional debt research is not free from antifraud, supervision, or conflict rules |
SEC Regulation AC
| Requirement | Practical meaning |
|---|
| Analyst certification in research reports | Analyst certifies the views accurately reflect personal views |
| Compensation certification | Analyst certifies no part of compensation was, is, or will be directly or indirectly related to the specific recommendation or views, unless properly disclosed |
| Public appearances | Analyst public statements require certification controls and records |
| Applies alongside FINRA rules | Regulation AC does not replace FINRA research disclosures or conflict restrictions |
| False certification risk | A technically included certification is not enough if the process contradicts it |
Regulation AC Exam Traps
| Trap | Correct approach |
|---|
| “The report has Regulation AC certification, so no FINRA disclosures are needed.” | Wrong. Reg AC certification and FINRA conflict disclosures are separate. |
| “Compensation can never include firmwide revenues.” | The issue is compensation tied to specific recommendations or views and required disclosure of relevant compensation factors. |
| “Public appearances are unregulated because they are oral.” | Wrong. Analyst public appearances require controls and disclosures. |
| “Certification fixes a misleading report.” | Wrong. Antifraud and communications standards still apply. |
FINRA Communications Classification
| Category | Audience test | Typical review approach | Series 161 issue |
|---|
| Retail communication | More than 25 retail investors within a 30-calendar-day period | Generally principal approval before first use, unless an exception applies | Research sent broadly to retail customers requires strict review |
| Correspondence | 25 or fewer retail investors within a 30-calendar-day period | Supervision and review under firm procedures | Personalized or limited distribution still cannot be misleading |
| Institutional communication | Institutional investors only | Supervision under firm procedures; not usually pre-use retail approval | If forwarded to retail, retail rules may be triggered |
| Internal communication | Within the firm only | Supervision, confidentiality, information barriers | Draft research can still create MNPI or conflict issues |
| Public appearance | Live or recorded analyst event | Disclosure and supervisory controls | Not a written report, but still regulated |
Content Standards for All Communications
| Standard | Practical test |
|---|
| Fair and balanced | Does the communication present material risks, not just benefits? |
| No false or misleading statements | Are facts accurate, current, and sourced? |
| No exaggerated claims | Avoid “guaranteed,” “safe,” “certain,” or unsupported superlatives |
| Reasonable basis | Is there support for recommendations, ratings, and price targets? |
| Clear separation of fact and opinion | Are assumptions and judgments identified as such? |
| Balanced performance discussion | Past performance is not presented as predictive |
| Appropriate audience | Is the content suitable for the sophistication and status of recipients? |
| Required disclosures | Are conflicts visible and understandable, not buried? |
| No omitted material facts | Would missing information change the total mix for a reasonable investor? |
Approval and Review Matrix
| Item | Pre-use approval or control | Who is involved | Key record |
|---|
| Firm-created equity research report | Approval under research and communications procedures | Supervisory analyst/research principal; legal/compliance as needed | Final report, approvals, disclosures, certifications |
| Firm-created debt research report | Approval/review based on retail or institutional status | Qualified principal/supervisory personnel | Final report, audience classification, approvals |
| Third-party research distributed by firm | Review for reliability, conflicts, and misleading content | Supervisory principal; research/compliance | Due diligence, disclosures, distribution record |
| Independent third-party research | Modified review may apply if independence conditions are met | Supervisory principal/compliance | Independence basis and conflict disclosures |
| Retail communication | Principal approval before first use unless exception applies | Appropriately registered principal | Approved version and approval evidence |
| Institutional communication | Supervision under written procedures | Designated supervisor | Sampling/review logs, if applicable |
| Correspondence | Supervision under written procedures | Designated supervisor | Review evidence under firm procedures |
| Public appearance by analyst | Disclosure and supervisory controls | Analyst; supervisor; compliance | Appearance records and certifications |
Third-Party Research
| Question | Why it matters |
|---|
| Who prepared it? | Determines whether it is firm research, third-party research, or independent third-party research |
| Did the firm influence it? | Influence can create adoption/entanglement and greater responsibility |
| Is the source reliable? | Firm should not distribute research it knows or has reason to know is false, biased, or unreliable |
| Are conflicts disclosed? | Distribution may require disclosure of firm, source, or issuer conflicts |
| Is it issuer-paid? | Issuer-paid research is a major conflict and should not be treated as independent |
| Did the firm excerpt or highlight it? | Selective excerpts can make a balanced report misleading |
Public Appearances by Research Analysts
| Scenario | Required mindset |
|---|
| TV interview discussing a covered issuer | Treat as public appearance; disclose material conflicts and comply with Reg AC controls |
| Conference panel with institutional investors | Still public appearance if analyst gives views publicly or semi-publicly |
| Webinar for clients | Analyze audience and content; may also be retail or institutional communication |
| Podcast discussing ratings | Oral format does not avoid research analyst standards |
| Interactive social media Q&A | Can create public appearance and communications supervision issues |
| Analyst repeats unpublished rating change | Potential selective disclosure and firm policy violation |
Analyst Personal Trading Controls
| Control | Purpose |
|---|
| Preclearance | Prevents trading ahead of reports or while in possession of sensitive research information |
| Restricted/watch lists | Blocks trading during offerings, pending rating changes, or MNPI concerns |
| Blackout periods | Prevent trading around publication or changes in rating/target |
| Contrary-trade restrictions | Prevent analyst accounts from trading against published recommendations without permitted exception |
| IPO/private placement controls | Prevent improper preferential allocations or conflicts |
| Household/account monitoring | Captures indirect trading through related or controlled accounts |
| Exception documentation | Hardship or other exceptions must be justified, approved, and recorded |
Investment Banking and Research: Permitted vs Prohibited
| Activity | Usually permitted? | Exam reasoning |
|---|
| Analyst conducts independent due diligence on an issuer | Yes | Research needs factual basis |
| Analyst meets issuer management for factual verification | Yes, with controls | Issuer cannot dictate conclusions |
| Legal/compliance reviews draft for conflicts | Yes | Conflict control, not content pressure |
| Investment banking reviews draft to suggest a higher rating | No | Improper influence |
| Investment banking verifies factual information through controlled process | Limited | Must not become approval or pressure |
| Analyst participates in investment banking pitch | No | Solicitation conflict |
| Analyst promises favorable research to win mandate | No | Prohibited inducement |
| Analyst joins road show to market an offering | No | Research cannot be sales arm of banking |
| Sales asks analyst to delay downgrade to help inventory | No | Trading pressure undermines independence |
| Analyst speaks to investors after report is broadly released | Yes, with supervision | Avoid selective disclosure and inconsistent statements |
| Concept | Practical test |
|---|
| Material information | Would a reasonable investor consider it important, or would it alter the total mix of information? |
| Nonpublic information | Not broadly disseminated to the market with time for investors to absorb it |
| MNPI result | Do not trade, tip, or publish research using the information until cleared |
| Information barrier | Separates research, investment banking, trading, and other sensitive functions |
| Wall crossing | Controlled process for sharing MNPI with need-to-know personnel |
| Restricted list | Limits trading or research when MNPI or conflicts exist |
| Watch list | Confidential monitoring list for potential issues |
| Mosaic theory | Analysts may combine public and immaterial nonpublic information; not a license to use MNPI |
| Escalation | When in doubt, stop and escalate to legal/compliance before publishing or trading |
Regulation FD and Selective Disclosure
| Point | Exam-ready rule |
|---|
| Primary target | Issuers, not analysts |
| Covered recipients | Includes securities market professionals such as analysts and broker-dealers |
| Intentional selective disclosure | Issuer should make simultaneous public disclosure |
| Unintentional selective disclosure | Issuer should make prompt public disclosure |
| Analyst receiving MNPI | Analyst and firm must avoid trading, tipping, or publishing based on MNPI |
| Trap | “The issuer violated Reg FD, so the analyst can use it.” Wrong. MNPI restrictions still apply. |
Antifraud and Liability Framework
| Rule or concept | What it prohibits | Research relevance |
|---|
| Exchange Act Rule 10b-5 | Fraud, material misstatements, omissions, and deceptive devices in connection with securities transactions | Misleading research, omitted conflicts, manipulated recommendations |
| Securities Act liability | Material misstatements or omissions in offering materials | Research around offerings must avoid becoming misleading sales material |
| FINRA communications standards | False, exaggerated, promissory, or unbalanced communications | Applies even without private litigation |
| Manipulation rules | Artificial price activity, rumors, matched orders, wash trades | Research cannot be used to move prices deceptively |
| Tender offer antifraud rules | Trading or tipping on tender offer information | Heightened sensitivity to deal rumors and banker information |
| Proxy rules | False or misleading proxy solicitations | Research touching proxy contests must be carefully reviewed |
| Concept | Why supervisory analysts care |
|---|
| Distribution participant restrictions | Firms involved in distributions may face limits on bidding for or purchasing covered securities |
| Stabilization and penalty bids | Offering-market activities are tightly controlled and disclosed |
| Research near offerings | Conflicts are heightened when the firm is an underwriter or expects compensation |
| Old quiet-period memorization | Be cautious with outdated fixed day-count rules; follow current FINRA/SEC rules and firm procedures |
| Exam trap | Disclosure may be required, but disclosure alone does not permit prohibited solicitation or manipulation |
Required Disclosures: What “Good” Looks Like
| Weak disclosure | Better disclosure approach |
|---|
| “We may have conflicts.” | Identify the actual conflict when required, such as investment banking compensation, market making, ownership, or analyst interest |
| “Target price is $50.” | Explain valuation method, time horizon, assumptions, and risks |
| “Outperform.” | Define rating meaning and benchmark or time horizon |
| “See website for important disclosures.” | Ensure required disclosures are clear, prominent, and accessible under the applicable rule |
| “Company is a client.” | Specify the type of services or compensation where required |
| “Analyst owns shares.” | Disclose analyst or household financial interest as required |
Supervisory Analyst Prepublication Checklist
Classify the communication
- Equity research, debt research, third-party research, retail communication, institutional communication, correspondence, or public appearance.
Identify the audience
- Retail, institutional, mixed, internal, or public.
Check independence
- No investment banking pressure, issuer control, sales/trading influence, or promised favorable coverage.
Verify content standards
- Fair, balanced, accurate, sourced, and not misleading.
Review recommendation support
- Rating, price target, valuation method, assumptions, and risks are reasonable and explained.
Confirm required disclosures
- Ownership, market making, compensation, banking role, analyst interest, rating distribution, valuation risks, and known material conflicts.
Confirm Regulation AC certification
- Analyst personal views and compensation certification included where required.
Review personal trading controls
- Analyst accounts, household accounts, blackout periods, and restricted lists checked.
Control non-research review
- Any issuer, banking, sales, or trading comments are permitted, documented, and not outcome-driven.
Approve and preserve records
- Maintain approval evidence, final version, disclosures, certifications, source support, and distribution details.
Handling Problems After Publication
| Problem discovered | Immediate response |
|---|
| Material factual error | Escalate, assess investor impact, correct or retract under firm procedures |
| Missing required conflict disclosure | Stop further distribution, escalate, issue corrected disclosure if required |
| Analyst had undisclosed financial interest | Escalate to compliance; review report, trading records, and supervisory failure |
| Report may be based on MNPI | Halt distribution, restrict trading, consult legal/compliance |
| Investment banking influenced rating | Escalate; review communications, approvals, compensation, and potential regulatory reporting |
| Selective early distribution | Identify recipients, stop leak, assess corrective broad distribution and records |
| Public appearance omitted conflicts | Document, correct where appropriate, and review analyst controls |
Books and Records Focus
| Record | Why it matters |
|---|
| Final research reports | Shows what was distributed |
| Drafts and approvals | Evidence of supervisory review and changes |
| Disclosure support | Shows basis for conflict disclosures |
| Regulation AC certifications | Required analyst certification evidence |
| Distribution lists | Determines retail/institutional treatment and selective disclosure issues |
| Personal trading records | Supports analyst account controls |
| Restricted/watch list records | Shows MNPI and conflict monitoring |
| Third-party research due diligence | Supports distribution decision |
| Public appearance records | Supports analyst disclosure and certification controls |
| Written supervisory procedures | Shows required supervisory system |
| Exception approvals | Demonstrates controlled deviations from normal policy |
Federal Securities Law Quick Reference
| Law or rule | High-yield supervisory analyst angle |
|---|
| Securities Act of 1933 | New issues, registration, prospectuses, offering communications, liability for material misstatements |
| Securities Exchange Act of 1934 | Broker-dealer regulation, trading markets, reporting companies, antifraud, manipulation |
| Investment Company Act of 1940 | Fund regulation; fund communications may be governed by product-specific rules |
| Investment Advisers Act of 1940 | Adviser fiduciary duties, conflicts, advertising; relevant when research overlaps advisory services |
| SEC Regulation AC | Analyst certifications in research and public appearances |
| SEC Regulation FD | Issuer selective disclosure to analysts and market professionals |
| SEC Regulation M | Trading restrictions during distributions |
| Exchange Act Rule 10b-5 | Antifraud rule most relevant to misleading research |
| Tender offer rules | Deal information is highly sensitive; no trading/tipping on tender offer MNPI |
| Proxy rules | Avoid false or misleading statements in proxy-related analysis |
Common Series 161 Traps
| Trap | Correct answer pattern |
|---|
| “If it is sent by email, it is correspondence, not research.” | It can be both a communication and a research report depending on content and audience. |
| “Institutional audience eliminates all disclosure requirements.” | Institutional treatment can modify review, but antifraud, supervision, and many conflict rules remain. |
| “Disclosure cures prohibited conduct.” | Some conduct is banned even if disclosed, such as promising favorable research for banking business. |
| “Only written reports require analyst controls.” | Public appearances and social media can trigger disclosures and Regulation AC controls. |
| “Issuer factual review means issuer approval.” | Issuer may verify facts under controls; issuer cannot approve conclusions. |
| “Investment banking can review for business impact.” | Improper. Banking influence over ratings, targets, or timing is a major violation. |
| “Debt research is the same as equity research.” | Debt rules have different retail/institutional structure and market-specific flexibility. |
| “Third-party research is not the firm’s responsibility.” | Distribution creates review, conflict, and anti-misleading obligations. |
| “A price target needs only a number.” | It needs basis, valuation method, assumptions, and risks. |
| “Analyst compensation cannot consider any firm performance.” | The key issue is linkage to specific recommendations/views or banking transactions and proper disclosure. |
| “MNPI can be used if it helps investors.” | No. Stop, restrict, and escalate. |
| “Old quiet-period day counts always control.” | Use current rules, question facts, and firm procedures. |
Scenario Drill Table
| Scenario | Best regulatory response |
|---|
| Banker asks analyst to raise rating before a secondary offering | Refuse, document/escalate; improper investment banking influence |
| Issuer CFO edits draft to remove risk language | Do not accept substantive pressure; factual corrections only under controls |
| Analyst wants to buy stock before initiating coverage with Buy rating | Likely prohibited or restricted; apply preclearance, blackout, and account rules |
| Institutional salesperson wants early copy for top clients | Do not selectively disclose unpublished research |
| Third-party report is issuer-paid but labeled independent | Treat as conflict; do not distribute as independent without proper review/disclosure |
| Analyst mentions a covered company on a podcast | Treat as public appearance; apply disclosures and certification controls |
| Research report omits that firm makes a market in the stock | Correct disclosure before publication; if published, escalate and remediate |
| Analyst receives nonpublic acquisition rumor from banker | Treat as potential MNPI; stop publication/trading and escalate |
| Report states “minimal risk” for distressed bonds | Likely misleading; must present balanced credit risks |
| Retail clients receive institutional debt note | Reclassify and apply retail protections or stop distribution |
Final Review Checklist
Before exam day, be able to answer these quickly:
- Is the item a research report, public appearance, communication, or something else?
- Is it equity research or debt research?
- Is the audience retail, institutional, or mixed?
- Which rule set applies: FINRA research rules, communications rules, Regulation AC, antifraud, or offering rules?
- Is the conduct prohibited, restricted with controls, or permitted with disclosure?
- What conflicts must be disclosed?
- Who must approve or supervise the communication?
- What records must be retained?
- What should the supervisory analyst do if a problem is discovered?
Practical Next Step
Work timed Series 161 regulation scenarios. For each question, force yourself to identify: communication type, audience, applicable rule, prohibited conduct, required disclosure, approval path, and recordkeeping requirement before reading the explanation.